# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Joe Louis (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX002-SYN
- Date: 2026-08-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Desmond Achterberg-Cole, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week review: psychotic symptoms, urine tests and blood pressure. **S**

## History of present illness

Mr. Louis returns four weeks after intake. About five days ago he noticed that he no longer believed he was being followed, and he now calls those fears part of the cocaine. He sleeps six to seven hours. In the first week of aripiprazole he felt a little restless in the evenings, which passed. All six contingency management urine tests have been negative, and he has drawn several prizes. He has had three therapy sessions and is working on what he does in the evenings and when he travels. His cold from the sick visit cleared within a week without a decongestant. His home blood pressure readings over the past week average 144/90. He met the social worker. He has signed a release allowing the clinic to talk with one family member he chose about his plan; no conversation has taken place yet. **S**

| Element | Detail |
|---|---|
| Cocaine | None for four weeks; six of six urine tests negative |
| Psychotic symptoms | Resolved about five days ago; insight full |
| Aripiprazole | Mild evening restlessness in the first week only |
| Home blood pressure | Average 144/90 mmHg over seven days |
| Mood | PHQ-9 4; GAD-7 5 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; sleeping six to seven hours |
| Cardiovascular | Negative | No chest pain, palpitations or breathlessness |
| Neurological | Negative | No restlessness now; no tremor |
| Psychiatric | Negative | No persecutory beliefs or hallucinations; no thoughts of suicide or of harming anyone |

4 systems reviewed. **S**

## Current medications

- Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives with **S**
- Aripiprazole 5 mg oral tablet, one tablet each morning **S**
- Amlodipine 5 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 146/92 mmHg; pulse 82 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 101.8 kg; BMI 29.1 kg/m². All vital signs are synthetic.

Urine albumin-to-creatinine ratio: 14 mg/g{creat}; PHQ-9: 4; GAD-7: 5. All results are synthetic.

## Change since baseline

- PHQ-9: 8 at baseline, 4 at this visit **S**
- GAD-7: 9 at baseline, 5 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 146/92, pulse 82; weight 101.8 kg, BMI 29.1 |
| Cardiovascular | Regular rhythm; no murmur; no carotid bruits |
| Neurological | No tremor or rigidity; no akathisia on observation; AIMS 0 |
| Psychiatric | Relaxed, warm and humorous; no delusional content; insight full |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Cocaine use disorder, severe, with cocaine-induced psychotic disorder** (F14.250). The persecutory delusions resolved within about four weeks of abstinence and just over two weeks of aripiprazole, which supports a substance-induced psychosis rather than a primary psychotic disorder. Four weeks without cocaine, confirmed by six negative urine tests. Safety reviewed: no thoughts of suicide or of harming anyone. **S**
   - Continue aripiprazole 5 mg; a taper will be discussed after about six weeks of remission.
   - Continue contingency management and weekly therapy.
2. **Hypertension, stage 2** (I10). Clinic 146/92 and home average 144/90 mmHg four weeks after his last cocaine use: stage 2 hypertension. Left ventricular hypertrophy by voltage on the intake ECG; urine albumin-to-creatinine ratio 14 mg/g; creatinine and potassium normal at intake. **S**
   - Amlodipine 5 mg daily, with lifestyle changes: less salt, regular walks and less alcohol.
   - Echocardiogram for left ventricular hypertrophy, with measurement of the aortic root and ascending aorta.
   - Home readings continued; target below 130/80 mmHg.
3. **Financial insecurity** (Z59.86). The social worker is helping with a budget and has referred him to a Low Income Taxpayer Clinic to review his old tax records. **S**
   - Tax clinic appointment next month.
   - Check his eligibility for veterans' benefits.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Self-management | Cocaine use since the last visit (his own account), cravings and triggers | Every visit | Completed today | No cocaine for four weeks; cravings less often |
| Laboratory | Urine drug tests in contingency management, with fentanyl, and prize draws for negative results | Twice weekly for twelve weeks, then at visits | Completed today | Six of six tests negative for cocaine and fentanyl; prizes drawn |
| Examination | Psychotic symptoms, insight and sleep | Every visit | Completed today | No persecutory beliefs for about five days; insight full; sleeping six to seven hours |
| Medication safety | Antipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS) | Weight and akathisia at every visit while on treatment; AIMS at baseline and every six months | Completed today | Weight 101.8 kg, up 0.8 kg; mild restlessness in the first week, now gone; no akathisia; AIMS 0 |
| Laboratory | Fasting glucose or hemoglobin A1c and lipids on an antipsychotic | Baseline, at four months, then yearly | Up to date | Baseline done; next at four months if he is still on aripiprazole |
| Examination | Cognitive screen (MoCA) | At baseline and again once he is well and off cocaine | Due | Repeat at the ten-week visit, after a longer time well |
| Examination | Blood pressure in clinic and at home | Every visit; home readings before diagnosis and after each change | Completed today | Clinic 146/92; home average 144/90 mmHg; stage 2 hypertension; amlodipine started |
| Laboratory | Urine albumin-to-creatinine ratio, creatinine and potassium at diagnosis of hypertension | At diagnosis, then yearly | Completed today | Urine albumin-to-creatinine ratio 14 mg/g; creatinine 1.16 mg/dL, eGFR 74 and potassium 4.1 mmol/L at intake |
| Imaging | Echocardiogram for stage 2 hypertension or left ventricular hypertrophy | At diagnosis | Ordered | Booked for the morning of the ten-week visit |
| Survey | Suicide and violence risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or of harming anyone; 988 in his phone |
| Medication safety | Naloxone and fentanyl test strips on hand | Every visit | Completed today | Naloxone and test strips still at home |
| Survey | Depression (PHQ-9) and anxiety (GAD-7) | At baseline and every four weeks while in treatment | Completed today | PHQ-9 4, item 9 scored 0; GAD-7 5 |
| Self-management | Cognitive behavioral therapy | Weekly | Completed today | Three sessions attended |
| Self-management | Finances, social work and taxpayer services | Every visit | Referred | Budget made with the social worker; Low Income Taxpayer Clinic appointment next month |
| Self-management | Family involvement, only with his consent | Every visit | Completed today | He signed a release for one family member he chose; no contact yet |

## Goal progress

- Persecutory fears gone and six or more hours of sleep. Outcome by 2026-08-10: No persecutory beliefs by four weeks; sleeping six to seven hours. **S**
- No cocaine use, his goal, with contingency management and cognitive behavioral therapy. In progress; target 2026-10-26. **S**
- Blood pressure below 130/80 mmHg. In progress; target 2026-10-26. **S**
- A clear answer about his memory and thinking once he is well. In progress; target 2026-09-21. **S**
- A plan for money that lets him sleep. In progress; target 2026-10-26. **S**

## Medication changes

- Started: Amlodipine 5 mg oral tablet, one tablet daily **S**

## Guideline basis

- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023), American Society of Addiction Medicine and American Academy of Addiction Psychiatry (Journal of Addiction Medicine 2024;18(1S Suppl 1):1-56)
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020), American Psychiatric Association (American Journal of Psychiatry 2020;177(9):868-872)
- Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021), Substance Abuse and Mental Health Services Administration
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026), Aether Forge

## Follow-up

- Preventive visit in five weeks. Ten-week review in six weeks with the echocardiogram that morning and the MoCA. Home readings daily for two weeks, then twice a week. **S**
- Next scheduled visit 2026-09-14: periodic adult preventive visit. **S**
